The FDA is postponing most foreign inspections through April due to the coronavirus outbreak, the agency said March 10.
The FDA regularly inspects foreign drugmakers, medical devicemakers and manufacturers of other U.S. imported goods.
The agency cited several reasons for the halt, including that there is a level 4 travel advisory from the State Department, prohibiting travel for all U.S. government employees.
The FDA said inspections deemed « mission-critical » will be considered on a case-by-case basis.
The agency added it is confident in its ability to maintain oversight of foreign manufacturers using alternative measures that have worked previously…